Application no. and date | 00926404.5 (espacenet) (Federated) (European Patent Register), 20000427 | Patent/reg. no. and date | DK/EP 1173197, 20041201 | Publication date | 20020123 | Priority no. and date | US 302596, 19990430 | EP pub. no. and date |
EP 1173197 20020123 | Effective date | | Applicant/owner | Amylin Pharmaceuticals, LLC, 9360 Towne Centre Drive
San Diego, CA 92121, US, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike Wilmington, DE 19850-5437, US | Applicant ref. no. | P38333 DK 01 | Inventor | COOLIDGE, Thomas, R., 3820 N.W. 46th Street
Lincoln, NE 68524, US, EHLERS, Mario, R., W., 3820 N.W. 46th Street
Lincoln, NE 68524, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/26 (2006.01) , A61P 9/10 (2006.01) , A61K 31/7004 (2006.01) , A61K 31/7004 (2006.01) , A61K 33/00 (2006.01) , A61K 38/06 (2006.01) , A61K 38/26 (2006.01) , A61K 38/26 (2006.01) , A61K 38/26 (2006.01) , A61K 38/26 (2006.01) , A61K 38/44 (2006.01) | Title | Metabolisk intervention med GLP-1 til forbedring af iskæmisk og reperfunderet vævs funktion | Int. application no. | US2000011251 | Int. publication no. | WO2000066138 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|